ArticleAging and disease2025
Epigenetic Clocks Identify Harmful Epigenetic Aging Linked to Depression Severity and Cognitive Deficits in Major Depressive Disorder.
Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epigenetic dysregulation in depression: molecular mechanisms, clinical biomarkers, and therapeutic opportunities.Journal of translational medicine · 2026Review
- Neuroinflammation and treatment resistance in major depressive disorder.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a prevalent mental illness characterized by significant morbidity and mortality. Cognitive impairment is a common feature of MDD, closely related to the aging process. Epigenetic aging calculated using DNA methylation is an important marker of biological aging. This study aims to investigate the relationships among MDD, epigenetic aging, and cognitive function. We assessed age acceleration using epigenetic clocks based on DNA methylation data in discovery dataset with 39 MDD patients and 40 healthy controls, and then validated the results in one independent MDD cohort with 359 cases and 68 controls. The results revealed that patients with MDD exhibited significantly greater age acceleration as measured by the DamAge clock and elevated mortality risk as indicated by the Zhang clock. Notably, the age acceleration of DamAge was positively correlated with depressive symptom severity. Epigenome-wide association study of the age acceleration of DamAge identified 1,472 significant CpG sites. Enrichment analyses further revealed that these CpG sites are potentially involved in cytoskeletal mechanisms, signaling pathways, and inflammatory response. Cognitive assessments showed significant correlations between emotion recognition task performance and age acceleration from multiple epigenetic clocks, suggesting a link between accelerated epigenetic aging and cognitive impairment in MDD. Our results underscore the potential role of epigenetic aging in understanding the biological underpinnings of MDD and its associated cognitive dysfunctions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.